Unichem Laboratories receives USFDA approval for Montelukast Sodium Tablets

09 Oct 2015 Evaluate

Unichem Laboratories has received ANDA approval from the United States Food and Drug Administration (USFDA) for Montelukast Sodium Tablets. Montelukast Sodium Tablets 10mg are therapeutically equivalent to Singulair Tablets 10mg of Merck Sharp & Dohme Corp.

Montelukast is a leukotriene receptor antagonist (LTRA). The product will be commercialized from Unichem’s Goa plant. The company now has total of 19 ANDA approvals (Including 3 Tentative Approvals) from USFDA.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.


Unichem Lab Share Price

689.85 -10.15 (-1.45%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.